An Evaluation of Weight Gain in Patients Treated with Dolutegravir vs. Other Core Agents (208943)

11/01/2019
02/07/2024
EU PAS number:
EUPAS27523
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

viiv-208943-protocol-redact

English (1.39 MB - PDF) View document
Study results
Study results

viiv-208943-clinical-study-report-redact

English (5.71 MB - PDF) View document
Study report
Other information